BioProcess International European Conference & Exhibition 2012

Find Winning Strategies to Improving Upstream, Downstream Processing, Manufacturing, Formulation and Analytics

What key sessions are driving the 2012 agenda?

1. Improve the speed, quality and cost of your upstream and cell culture processes

2. Ensure product consistency and in-depth process characterisation

3. Meet the critical CMC, regulatory and development standards needed to bring mAb biosimilars

4. Identify and evaluate the new downstream technologies driving down production costs.

5. Design an effective formulation strategy.

BRAND NEW SESSIONS FOR 2012!

-Risk mitigation strategies for raw materials

-Upstream and downstream challenges for novel therapies

-Biomanufacturing in the face of increased product titres

-New affinity ligands and non-chromographic methods to reduce the cost of downstream purification

-Impact of protein-to-protein interactions on formulations

-Technology transfer of processes, analytical methods and to CMOs

-SME showcase featuring the innovative new companies, products and processes shaping the industry

-Feedback on the recent Process Validation Guideline and companys' struggles to date